CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 278,096	$ 62,417
Short-term marketable securities	72,749	52,491
Related party receivables from collaborative arrangements	79,427	83,286
Prepaid expenses and other current assets	962	849
Total current assets	431,234	199,043
Property and equipment, net	33	160
Capitalized fees paid to a related party, net	139,076	152,899
Deferred tax assets, net	154,171	196,054
Other assets	312	37
Total assets	724,826	548,193
Current liabilities:
Accounts payable	10	11
Accrued personnel-related expenses	647	470
Accrued interest payable	4,152	4,264
Other accrued liabilities	562	955
Total current liabilities	5,371	5,700
Long-term debt, net of discount and issuance costs	377,120	382,855
Other long-term liabilities	219	586
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding	0	0
Common stock: $0.01 par value, 200,000 shares authorized, 101,288 and 101,098 issued and outstanding as of December 31, 2019 and 2018, respectively	1,013	1,011
Additional paid-in capital	1,258,859	1,256,267
Accumulated other comprehensive income (loss)	27	(3)
Accumulated deficit	(946,404)	(1,103,692)
Total Innoviva stockholders' equity	313,495	153,583
Noncontrolling interest	28,621	5,469
Total stockholders' equity	342,116	159,052
Total liabilities and stockholders' equity	$ 724,826	$ 548,193